ZUSAMMENSETZUNG MIT DUTASTERID

European patent · EP3893845 · In force

Register entry

Publication number
EP3893845
Application number
EP19895962
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 13, 2019
Published
Oct 20, 2021
Granted
Aug 20, 2025
Protection ends at the latest
Dec 12, 2039
Next annual fee due
Dec 31, 2026
IPC classes
A61K 31/58 (2006.01)
A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
A61K 47/22 (2006.01)
A61K 47/12 (2006.01)
A61K 47/14 (2017.01)
A61K 47/20 (2006.01)
A61K 47/10 (2017.01)
A61K 47/44 (2017.01)
A61P 13/08 (2006.01)
A61P 17/14 (2006.01)
A61P 5/24 (2006.01)
Priority
KR 20180162464 14.12.2018
PCT application
PCT/KR2019/017738 13.12.2019
PCT publication
WO2020/122681 18.06.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Change

    Published in Swissreg on 01.07.2026

  2. Jan 6, 2026

    Next annual fee due on

    Next annual fee due on
    31.12.2025 → 31.12.2026

    Published in Swissreg on 06.01.2026

  3. Oct 17, 2025

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 17.10.2025

  4. Aug 20, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 20.08.2025

Parties

Inventor

PARK, Tae Hyun

Yongin-si Gyeonggi-do 16995, KR

KO, Ki Seong

Yongin-si Gyeonggi-do 16995, KR

PARK, So Hyun

Yongin-si Gyeonggi-do 16995, KR

NOH, Sang Myoung

Yongin-si Gyeonggi-do 16995, KR

LIM, Jong Lae

Yongin-si Gyeonggi-do 16995, KR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.